Effect of Inhalation Therapy on Children's Fear and Anxiety Levels and Physiological Parameters
Inhalation With Toy Figure and Sound Insulated Nebulizer Effect of Treatment on Children's Fear and Anxiety Levels and Physiological Parameters: Randomized Controlled Study
1 other identifier
interventional
90
1 country
1
Brief Summary
The research was planned as a randomized controlled study. Between July 2023 and July 2025, he was hospitalized in the pediatric emergency department of Recep Tayyip Erdogan University Training and Research Hospital and was treated with a nebulizer. It includes children aged 3-6 and their mothers receiving treatment. The sample of the research will consist of 120 children and their mothers who applied to the pediatric emergency department between the specified dates and met the inclusion criteria and volunteered to participate in the research. "Introductory Information Form", "Child Fear Scale", "Emotional Indicators Scale in Children", "Physiological Parameter Tracking Form" will be used to collect data. "Nebulizer with Toy Figure", "Sound Insulated (Silent) Nebulizer" and "Toy with Fish Figure" will be used as research materials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2024
CompletedFirst Submitted
Initial submission to the registry
May 3, 2024
CompletedFirst Posted
Study publicly available on registry
July 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2025
CompletedAugust 1, 2025
July 1, 2025
12 months
May 3, 2024
July 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Child Fear Scale
This scale was developed to measure the anxiety levels in children. The facial muscle changes in expressions of fear have been illustrated by a graphic artist based on photographs of frightened faces. The scale can be used by families, children, or researchers to assess children. It presents a scale containing five facial expressions, scored between 0 and 4. A score of 0 indicates no fear or anxiety, while a score of 4 indicates the highest level of fear or anxiety. These are recognized as: "0" neutral expression (no anxiety), "1" very slight fear (very low anxiety), "2" mild fear (mild anxiety), "3" more fear (increased anxiety), "4" the most extreme fear (severe anxiety). This scale can be applied to measure fear and anxiety before and during medical procedures.
one year
Emotional Indicators Scale for Children
This scale is an easily administered and evaluated tool used to objectively identify emotional responses of children to medical procedures. The emotional indicators on the scale are assessed based on five parameters: facial expression, voice, activity, interaction, and cooperation level. These five parameters are scored from 1 to 5, with the lowest possible score being 5 and the highest being 25. The scale has a Cronbach's alpha reliability coefficient of 0.88. In this study, the scale will be utilized to assess the emotional indicators of children during inhalation therapy.
one year
Study Arms (3)
Control Group: Routine clinical practice
NO INTERVENTIONFear, Emotional Indicators and Physiological Parameters in Children
Therapeutic play: Fish-shaped nebulizer and fish-shaped toy
EXPERIMENTALFear, Emotional Indicators and Physiological Parameters in Children
silent nebulizer
EXPERIMENTALFear, Emotional Indicators and Physiological Parameters in Children
Interventions
In order to reduce the child's fear and anxiety, it is planned to apply inhalation therapy using a nebulizer with a red fish figure and an amigurumi toy with a red fish figure.
It is planned to apply inhalation therapy using a silent nebulizer to reduce the child's fear and anxiety.
Eligibility Criteria
You may qualify if:
- Having a child between the ages of 3-6
- Nebulizer and inhaler treatment will be applied
- The child does not have a mental or neurological disability
- Applying due to respiratory system disease
- The presence of the child's mother during the application period
- Mother and child can speak Turkish
- The mother does not have any obstacle to communication
- Mother's literacy
- Parent and child volunteering to participate in the research.
You may not qualify if:
- The child and parent have previously experienced inhalation therapy with a nebulizer.
- The child is hyperthermic (body temperature is 38 C and above)
- The child has pain,
- The child is in the terminal period,
- The parent has a condition that prevents him/her from evaluating the scale (mental disability, etc.).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Recep Tayyip Erdoğan University Faculty of Health Sciences
Rize, Güneysu, 53100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mehtap METİN KARAASLAN
Recep Tayyip Erdogan Universİty
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Study Director
Study Record Dates
First Submitted
May 3, 2024
First Posted
July 3, 2024
Study Start
May 1, 2024
Primary Completion
April 30, 2025
Study Completion
May 30, 2025
Last Updated
August 1, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share